The U.S. Supreme Court has issued a temporary ruling that maintains access to the abortion pill mifepristone by mail, allowing telehealth prescriptions to continue while a larger legal battle unfolds. As justices deliberated, opinions divided on whether abortion should be regulated federally or by individual states. The decision has prompted both support and opposition, with critics warning about potential dangers and asserting that restrictions could lead to dire consequences for women’s health. Following this ruling, abortion providers are bracing for continued disruptions as legal challenges persist, with various states and advocacy groups preparing for potential shifts in abortion access.